Status: Recruiting
A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults
This is a randomized, double-blind, placebo-controlled, multiple-ascending-dose study of SN2001 in healthy adult subjects. The study is designed to evaluate the safety, tolerability and immunogenicity of SN2001.
Participants needed: 36
Trial details
Phase: Phase 1Age: 18-55Biological sex: MaleType: InterventionalSponsor: Chimivac INCUpdated: Aug 24, 2025Locations: 1
Eligibility criteria
Age 18 to 55 years, inclusive. [+13]
History of Hepatitis B virus (HBV) infection as evidenced by detection of HBV Su... [+22]